Key Financial Data Of Reporting Company

Fuso Pharmaceutical Industries,Ltd. - Filing #7252924

Concept As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
60,563,000,000 JPY
55,407,000,000 JPY
51,015,000,000 JPY
49,632,000,000 JPY
49,251,000,000 JPY
Ordinary profit (loss)
3,780,000,000 JPY
1,868,000,000 JPY
2,215,000,000 JPY
1,996,000,000 JPY
2,227,000,000 JPY
Profit (loss)
-3,288,000,000 JPY
1,377,000,000 JPY
1,605,000,000 JPY
1,483,000,000 JPY
1,607,000,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
Total number of issued shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
Net assets
33,043,000,000 JPY
36,661,000,000 JPY
35,649,000,000 JPY
34,532,000,000 JPY
33,683,000,000 JPY
Total assets
81,729,000,000 JPY
75,802,000,000 JPY
72,466,000,000 JPY
69,334,000,000 JPY
69,876,000,000 JPY
Net assets per share
3,869.10
4,290.55
4,064.76
3,936.70
3,839.54
Dividend paid per share
82.00
70.00
70.00
60.00
60.00
Interim dividend paid per share
40.00
35.00
30.00
30.00
30.00
Basic earnings (loss) per share
-384.95
159.98
183.07
169.09
183.18
Diluted earnings per share
Equity-to-asset ratio
0.404 xbrli:pure
0.484 xbrli:pure
0.492 xbrli:pure
0.498 xbrli:pure
0.482 xbrli:pure
Rate of return on equity
-0.094 xbrli:pure
0.038 xbrli:pure
0.046 xbrli:pure
0.043 xbrli:pure
0.049 xbrli:pure
Price-earnings ratio
-6.3 xbrli:pure
13.8 xbrli:pure
10.9 xbrli:pure
12.9 xbrli:pure
13.9 xbrli:pure
Payout ratio
-0.213 xbrli:pure
0.438 xbrli:pure
0.382 xbrli:pure
0.355 xbrli:pure
0.328 xbrli:pure
Net cash provided by (used in) operating activities
-3,305,000,000 JPY
627,000,000 JPY
2,853,000,000 JPY
3,498,000,000 JPY
3,230,000,000 JPY
Net cash provided by (used in) investing activities
-3,168,000,000 JPY
-3,536,000,000 JPY
-1,373,000,000 JPY
-1,553,000,000 JPY
-978,000,000 JPY
Net cash provided by (used in) financing activities
7,618,000,000 JPY
14,000,000 JPY
-813,000,000 JPY
-1,671,000,000 JPY
-2,446,000,000 JPY
Cash and cash equivalents
6,264,000,000 JPY
5,120,000,000 JPY
8,014,000,000 JPY
7,347,000,000 JPY
7,074,000,000 JPY
Number of employees
1,279 xbrli:pure
1 xbrli:pure
60 xbrli:pure
1,340 xbrli:pure
1,307 xbrli:pure
1,314 xbrli:pure
1,344 xbrli:pure
1,356 xbrli:pure
Total shareholder return
1.330 xbrli:pure
1.176 xbrli:pure
1.044 xbrli:pure
1.102 xbrli:pure
1.245 xbrli:pure
Total return on share price index
2.134 xbrli:pure
2.168 xbrli:pure
1.534 xbrli:pure
1.450 xbrli:pure
1.421 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.